Fonar Corp (FONR)

16.09 -0.11 (-0.68%) USD  |  NASDAQ  |  Apr 23, 16:00
16.04 -0.05 (-0.31%) After-Hours: 20:00
More

Fonar Research and Development Expense (Quarterly): 0.416M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
December 31, 2023 0.416M
September 30, 2023 0.467M
June 30, 2023 0.4417M
March 31, 2023 0.435M
December 31, 2022 0.342M
September 30, 2022 0.349M
June 30, 2022 0.3852M
March 31, 2022 0.354M
December 31, 2021 0.37M
September 30, 2021 0.386M
June 30, 2021 0.393M
March 31, 2021 0.419M
December 31, 2020 0.424M
September 30, 2020 0.40M
June 30, 2020 0.4354M
March 31, 2020 0.535M
December 31, 2019 0.583M
September 30, 2019 0.472M
June 30, 2019 0.4443M
March 31, 2019 0.381M
December 31, 2018 0.55M
September 30, 2018 0.437M
June 30, 2018 0.4977M
March 31, 2018 0.503M
December 31, 2017 0.407M
Date Value
September 30, 2017 0.349M
June 30, 2017 0.3757M
March 31, 2017 0.332M
December 31, 2016 0.361M
September 30, 2016 0.412M
June 30, 2016 0.3888M
March 31, 2016 0.395M
December 31, 2015 0.412M
September 30, 2015 0.436M
June 30, 2015 0.6964M
March 31, 2015 0.36M
December 31, 2014 0.359M
September 30, 2014 0.397M
June 30, 2014 0.6328M
March 31, 2014 0.36M
December 31, 2013 0.374M
September 30, 2013 0.395M
June 30, 2013 0.4076M
March 31, 2013 0.381M
December 31, 2012 0.32M
September 30, 2012 0.33M
June 30, 2012 0.3047M
March 31, 2012 0.315M
December 31, 2011 0.293M
September 30, 2011 0.329M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.342M
Minimum
Dec 2022
0.583M
Maximum
Dec 2019
0.4238M
Average
0.419M
Median
Mar 2021

Research and Development Expense (Quarterly) Benchmarks

XWELL Inc --
ProPhase Labs Inc 0.274M
Applied DNA Sciences Inc 0.9358M
Veracyte Inc 18.67M
OncoCyte Corp 2.547M